z-logo
open-access-imgOpen Access
Cyclo(phenylalanine‐proline) induces DNA damage in mammalian cells via reactive oxygen species
Author(s) -
Lee Kwanghyun,
Jeong Jae Eun,
Kim In Hwang,
Kim KunSoo,
Ju BongGun
Publication year - 2015
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.12678
Subject(s) - reactive oxygen species , phenylalanine , proline , chemistry , dna damage , dna , biochemistry , oxygen , microbiology and biotechnology , biology , amino acid , organic chemistry
Cyclo(phenylalanine‐proline) is produced by various organisms such as animals, plants, bacteria and fungi. It has diverse biological functions including anti‐fungal activity, anti‐bacterial activity and molecular signalling. However, a few studies have demonstrated the effect of cyclo(phenylalanine‐proline) on the mammalian cellular processes, such as cell growth and apoptosis. In this study, we investigated whether cyclo(phenylalanine‐proline) affects cellular responses associated with DNA damage in mammalian cells. We found that treatment of 1 mM cyclo(phenylalanine‐proline) induces phosphorylation of H2 AX (S139) through ATM ‐ CHK 2 activation as well as DNA double strand breaks. Gene expression analysis revealed that a subset of genes related to regulation of reactive oxygen species (ROS) scavenging and production is suppressed by the cyclo(phenylalanine‐proline) treatment. We also found that cyclo(phenylalanine‐proline) treatment induces perturbation of the mitochondrial membrane, resulting in increased ROS , especially superoxide, production. Collectively, our study suggests that cyclo(phenylalanine‐proline) treatment induces DNA damage via elevation of ROS in mammalian cells. Our findings may help explain the mechanism underlying the bacterial infection‐induced activation of DNA damage response in host mammalian cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here